CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $2.85 billion as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-05
- 2026-06-27: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.85B.
- 2026-03-28: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.95B.
- 2025-12-27: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.17B.
- 2025-09-27: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.41B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-27 | $2.85B 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $2.95B 10-Q · filed 2026-08-05 | |
| 2025-12-27 | $3.17B 10-Q · filed 2026-08-05 | |
| 2025-09-27 | $3.41B 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $3.36B 10-Q · filed 2026-08-05 | |
| 2025-03-29 | $3.20B 10-Q · filed 2026-08-05 | |
| 2024-12-28 | $3.47B 10-Q · filed 2026-08-05 | |
| 2024-09-28 | $3.79B 10-Q · filed 2025-11-05 | |
| 2024-06-29 | $3.73B 10-Q · filed 2025-11-05 | |
| 2024-03-30 | $3.65B 10-Q · filed 2025-11-05 | |
| 2023-12-30 | $3.60B 10-K · filed 2026-02-18 | |
| 2023-09-30 | $3.31B 10-Q · filed 2024-11-06 | |
| 2023-07-01 | $3.26B 10-Q · filed 2024-11-06 | |
| 2023-04-01 | $3.11B 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $2.98B 10-K · filed 2026-02-18 | |
| 2022-09-24 | $2.63B 10-Q · filed 2023-11-08 | |
| 2022-06-25 | $2.65B 10-Q · filed 2023-11-08 | |
| 2022-03-26 | $2.61B 10-Q · filed 2023-11-08 | |
| 2021-12-25 | $2.54B 10-K · filed 2025-02-19 | |
| 2021-09-25 | $2.43B 10-Q · filed 2022-11-02 | |
| 2021-06-26 | $2.32B 10-Q · filed 2022-11-02 | |
| 2021-03-27 | $2.19B 10-Q · filed 2022-11-02 | |
| 2020-12-26 | $2.12B 10-K · filed 2024-02-14 | |
| 2020-09-26 | $1.90B 10-Q · filed 2021-11-03 | |
| 2020-06-27 | $1.76B 10-Q · filed 2021-11-03 | |
| 2020-03-28 | $1.66B 10-Q · filed 2021-11-03 | |
| 2019-12-28 | $1.64B 10-K · filed 2023-02-22 | |
| 2019-09-28 | $1.54B 10-Q · filed 2020-10-29 | |
| 2019-06-29 | $1.46B 10-Q · filed 2020-10-29 | |
| 2019-03-30 | $1.40B 10-Q · filed 2020-10-29 | |
| 2018-12-29 | $1.32B 10-K · filed 2022-02-16 | |
| 2018-09-29 | $1.26B 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $1.19B 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $1.14B 10-Q · filed 2019-11-06 | $1.14B 10-Q · filed 2019-05-07 |
| 2017-12-30 | $1.05B 10-K · filed 2021-02-17 | |
| 2016-12-31 | $839.13M 10-K · filed 2020-02-11 | |
| 2015-12-26 | $737.56M 10-K · filed 2019-02-13 | |
| 2014-12-27 | $675.93M 10-K · filed 2018-02-13 | |
| 2013-12-28 | $644.08M 10-K · filed 2017-02-14 | $664.66M 10-K · filed 2014-02-25 |
| 2012-12-29 | $603.20M 10-K · filed 2016-02-12 | |
| 2012-09-29 | $599.95M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $564.85M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $554.50M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $527.36M 10-K · filed 2015-02-17 | |
| 2011-09-24 | $541.37M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $590.63M 10-Q · filed 2011-08-03 | |
| 2011-03-26 | $564.33M 10-Q · filed 2011-05-04 | |
| 2010-12-25 | $527.36M 10-K · filed 2014-02-25 | $688.73M 10-K · filed 2011-02-23 |
| 2010-09-25 | $1.04B 10-Q · filed 2011-11-02 | |
| 2010-06-26 | $1.39B 10-Q · filed 2011-08-03 | |
| 2009-12-26 | $688.73M 10-K · filed 2014-02-25 | $1.37B 10-Q · filed 2010-08-03 |
| 2008-12-27 | $1.24B 10-K · filed 2012-02-27 | |
| 2007-12-29 | $1.91B 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |